Giant cell arteritis with Cerebro-vascular involvement research hub

Efficacy of Tocilizumab in association to steroids in giant cell arteritis with cerebro-vascular involvement patients (ToGiAS). A french prospective multicentre randomized versus placebo phase III trial (TOGIAC)

This study looks at a medicine called tocilizumab, together with common steroid treatments, for people in the UK with a specific type of giant cell arteritis that affects the brain. It aims to see if this combination can prevent new problems and help people get better.